This inventor holds 1 USPTO granted patent. Top assignee: The Salk Institute. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Kazuhiko Uemsono: Innovator in Retinoic Acid Receptor Research
Introduction
Kazuhiko Uemsono is a prominent inventor based in San Diego, CA (US). He is known for his significant contributions to the field of biological studies, particularly in the area of retinoic acid receptors. His innovative work has led to the development of novel receptor compositions that have implications in various biological processes.
Latest Patents
Uemsono holds a patent for a novel retinoic acid receptor composition. This invention discloses a unique receptor encoded by cDNA carried on plasmid phRAR1, which has been deposited with the American Type Culture Collection for patent purposes. The patent also includes chimeric receptor proteins, constructed by exchanging functional domains between various hormone receptors, such as glucocorticoid, mineralocorticoid, estrogen-related, thyroid, and retinoic acid receptors. Furthermore, Uemsono's patent outlines a novel method for identifying functional ligands for receptor proteins, utilizing the modular structure of hormone receptors.
Career Highlights
Kazuhiko Uemsono has made significant strides in his career at The Salk Institute for Biological Studies. His research has focused on understanding the mechanisms of hormone receptors and their interactions with ligands. His innovative approaches have contributed to advancements in the field of molecular biology.
Collaborations
Uemsono has collaborated with notable scientists, including Ronald Mark Evans and Estelita S Ong. These collaborations have further enriched his research and have led to impactful findings in the realm of biological studies.
Conclusion
Kazuhiko Uemsono's work in retinoic acid receptor research exemplifies the importance of innovation in biological sciences. His contributions continue to influence the understanding of hormone receptor mechanisms and their applications in various fields.
